Photosensitizer Used in Clinical Photodynamic Thearpy for Cancer

doi:10.3724/SP.J.1095.2013.30375

Chinese Journal of Applied Chemistry

• Review • Previous Articles Next Articles

Photosensitizer Used in Clinical Photodynamic Thearpy for Cancer

LIU Hong, XUE Jinping, JIANG Zhou, CHEN Naisheng^*, HUANG Jinling^*

(College of Chemistry and Chemical Engineering,Fuzhou University,Fuzhou 350108,China)

Received:2013-07-24 Revised:2013-10-24 Published:2013-12-10 Online:2013-12-10
About author:

Abstract

Abstract: Photodynamic therapy(PDT) has emerged as a selective and non-invasive modality for the treatment of malignant tumors. Photosensitizers are the key component of PDT, which generates cytotoxic reactive oxygen species(ROS) in the presence of oxygen and light with appropriate wavelength. In clinical practice, three families of photosensitizer(PS) are used, including porphyrins, chlorophylls and bacteriochloyin/phthalocyanines. This review focused on the oncologic photosensilizers that were in clinical uses or trials and from the points of view of successful photosensitizers explored the future trends of PS and PDT.

Key words: photodynamic therapy, photosensitizer, photosensitizer types, photosensitizer structure, photodynamic reaction

CLC Number:

O622.6

LIU Hong, XUE Jinping, JIANG Zhou, CHEN Naisheng*, HUANG Jinling*. Photosensitizer Used in Clinical Photodynamic Thearpy for Cancer[J]. Chinese Journal of Applied Chemistry, DOI: 10.3724/SP.J.1095.2013.30375.

References

[1] Dougherty T J. Photodynamic Therapy(PDT) of Malignant Tumors[J]. Crit Rev Oncol Hematol,1984,2:83-116.

[2] Brown S. Photodynamic Therapy:Two Photons are Better than One[J]. Nat Photon,2008,2:394-395.

[3] Idris N M,Gnanasammandhan M K,Zhang J,et al. In vivo Photodynamic Therapy Using Upconversion Nanoparticles as Remote-controlled Nanotransducers[J]. Nat Med,2012,18:1580-1585.

[4] Brasseur N,Ali H,Autenrieth D,et al. Biological Activities of Phthalocyanines-Ⅲ.Photoinactivation of V-79 Chinese Hamster Cells by Tetrasulfophthalocyanines[J]. Photochem Photobiol,1985,42:515-521.

[5] Jia X,Yang F F,Li J,et al. Synthesis and in Vitro Photodynamic Activity of Oligomeric Ethylene Glycol-Quinoline Substituted Zinc(Ⅱ) Phthalocyanine Derivatives[J]. J Med Chem,2013,56:5797-5805.

[6] Dennis E J,Dolmans G J,Dai F,et al. Photodynamic Therapy for Cancer[J]. Nat Rev Cancer,2003,3(3):380-387.

[7] Charles J G. Photodynamic Therapy-methods and Protocols[M]. New York:Humana Press,2010:26-28.

[8] Allison R R,Downie G H,Cuenca R,et al. Photosensitizers in Clinical PDT[J]. Photodiagnosis Photodyn Ther,2004,1:27-42.

[9] Mroz P,Yaroslavsky A,Kharkwal G B,et al. Cell Death Pathways in Photodynamic Therapy of Cancer[J]. Cancers,2011,3:2516-2539.

[10] Oleinick N L,Morris R L,Belichenko I. The Role of Apoptosis in Response to Photodynamic Therapy:What, Where, Why, and How[J]. Photochem Photobiol Sci,2002,1:1-21.

[11] Igney F H,Krammer P H. Death and Anti-death:Tumour Resistance to Apoptosis[J]. Nat Rev Cancer,2002,2:277-288.

[12] Boyle R W,Dolphin D. Structure and Biodistribution Relationships of Photodynamic Sensitizers[J]. Photochem Photobiol,1996,64:469-485.

[13] Hamblin M R,Newman E L. On the Mechanism of the Tumour-localising Effect in Photodynamic Therapy[J]. J Photochem Photobiol B,1994,23:3-8.

[14] Jori G,Reddi E. The Role of Lipoproteins in the Delivery of Tumour-targeting Photosensitizers[J]. Int J Biochem,1993,25:1369-1375.

[15] Castano A P,Demidova T N,Hamblin M R. Mechanisms in Photodynamic Therapy:Part Three. Photosensitizer Pharmacokinetics, Biodistribution, Tumor Localization and Modes of Tumor Destruction[J]. Photodiagnosis Photodyn Ther,2005,2:91-106.

[16] Castano A P,Demidova T N,Hamblin M R. Mechanisms in Photodynamic Therapy:Part Two.Cellular Signaling, Cell Metabolism and Modes of Cell Death[J]. Photodiagnosis Photodyn Ther，2005，2:1-23.

[17] Juarranz A,Jaen P,Sanz-Rodriguez F,et al. Photodynamic Therapy of Cancer. Basic Principles and Applications[J]. Clin Transl Oncol,2008,10(3):148-154.

[18] Ron R A,Claudio H S. Oncologic Photodynamic Therapy Photosensitizers:A Clinical Review[J]. Photodiagnosis Photodyn Ther,2010,7:61-75.

[19] Ron R A,Gordon H D,Rosa Cuenca,et al. Photosensitizers in Clinical PDT[J]. Photodiagnosis Photodyn Ther,2004,1:27-42.

[20] Huang Z. An Update on the Regulatory Status of PDT Photosensitizers in China[J]. Photodiagnosis Photodyn Ther,2008,5:285-287.

[21] Allison R R,Sibata C H. Photodiagnosis for Cutaneous Malignancy:A Brief Clinical and Technical Review[J]. Photodiagnosis Photodyn Ther,2008,5:247-250.

[22] Michael R D,Scott L G,Stephen J W. Current Clinical and Preclinical Photosensitizers for Use in Photodynamic Therapy[J]. J Med Chem,2004,47(16):3897-3915.

[23] LI Xufei,XUE Jinping,CHEN Naisheng,et al. Photo-generating Singlet Oxygen Ability of Metallophthalocyanines Substituted with Aromaticoxy Group Containing Nitrogen[J]. Chinese J Appl Chem,2007，24（9）:1041-1044(in Chinese).

李旭飞,薛金萍,陈耐生,等. 含氮芳氧基取代酞菁金属配合物光敏产生1O2的研究[J]. 应用化学,2007，24（9）:1041-1044.

[24] Xue J P,Cai L X,Chen N S，et al. Synthesis and Photophysical Properties of Zinc Phthalocyanines Substituted with Quinolinoxy Group[J]. J Porphyrins Phthalocyanines,2009,13:1206-1213.

[25] Nagao Kobayashi,Hiroshi Ogata,Naokazu Nonaka,et al. Effect of Peripheral Substitution on the Electronic Absorption and Fluorescence Spectra of Metal-Free and Zinc Phthalocyanines[J]. Chem Eur J,2003,9:5123-5134.

[26] HUANG Jingling,HUANG Jiandong,LIU Ersheng,et al. Some Relationships Between Structures and Photodynamic Anti-cancer Activities of Phthalocyanines[J]. Acta Phys-Chim Sin,2001,17(7):662-671(in Chinese).

黄金陵，黄剑东，刘尔生，等. 酞菁配合物的结构与其光动力抗癌活性[J]. 物理化学学报，2001,17(7):662-671.

[27] Tebello Nyokong. Effects of Substituents on the Photochemical and Photophysical Properties of Main Group Metal Phthalocyanines[J]. Coord Chem Rev,2007,251:1707-1722.

[28] Ishii K,Kobayashi N. In:Kadish K M,Smith K M,Guilard E,Eds. [M] The Porphyrin Handbook,Chapter 1,vol. 16,Elsevier,2003(chapter 1).

[29] Raymond Bonnett. Chemical Aspects of Photodynamic Therapy[M]. Gordon and Breach Science Pulishers,(Australia Canada France Germany India Japan Luxembourg Malaysia The Netherlands Russia Singapore Switzerland),2000,1:144.

[30] Mang T S. Lasers and Light Sources for PDT:Past, Present and Future[J]. Photodiagnosis Photodyn Ther,2004,1:43-48.

[31] Allison R R. Future PDT[J]. Photodiagnosis Photodyn Ther,2009,6:231-234.

[32] Allison R R,Bagnato V S,Sibata C H. Future of Oncologic Photodynamic Therapy[J]. Future Oncol,2010,6:929-940.

[33] Ron R A,Keyvan M. Photodynamic Therapy(PDT):PDT Mechanism[J]. Clin Endosc,2013,46:24-29.

[34] Nawal S,Hubert van den B,Norbert L. Like a Bolt from the Blue:Phthalocyanines in Biomedical Optics[J]. Molecules,2012,17:98-144.

[35] Chen B,Roskams T,de Witte P A. Antivascular Tumor Eradication by Hypericin-mediated Photodynamic Therapy[J]. Photochem Photobiol,2002,76:509-513.

Photosensitizer Used in Clinical Photodynamic Thearpy for Cancer

PDF

Knowledge

Cited

Abstract

Cite this article

share this article

References

Related Articles 3

Recommended Articles

Metrics

Comments

[1]	ZHOU Ying, LIU Sai-Nan, CAI Li-Han, ZHANG Jian-Fu, PANG Mao-Lin. Ion-doped Poly(2-nitro-1,4-phenylenediamine) Nanospheres for Synergistic Photo- and Chemo-Dynamic Therapy [J]. Chinese Journal of Applied Chemistry, 2021, 38(2): 0-0.
[2]	ZHOU Ying, LIU Sai-Nan, CAI Li-Han, ZHANG Jian-Fu, PANG Mao-Lin. Ion-doped Poly(2-nitro-1,4-phenylenediamine) Nanospheres for Synergistic Photo- and Chemo-Dynamic Therapy [J]. Chinese Journal of Applied Chemistry, 2021, 38(2): 181-187.
[3]	WANG Yupeng, ZHOU Dongfang, CHENG Yanxiang, HUANG Yubin. Hemoglobin/Photosensitizer Compound Drug System for Photodynamic Therapy [J]. Chinese Journal of Applied Chemistry, 2018, 35(12): 1442-1448.